Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
《大行》里昂:百濟神州首季首次實現盈虧平衡 降目標價至205.8港元

2025-05-08T  
《業績》百濟神州第一季GAAP淨利潤127萬美元 虧轉盈

2025-05-07T  
百濟神州:Pharmacyclics針對公司專利侵權指控無效

2025-04-30T  
據報內地要求製藥企業和醫院研究替代美國進口產品可行性

2025-04-29T  
《大行》大和列出內地基金首季對中資重倉股按季持股增加最多股份名單(表)

2025-04-29T  
《大行》大摩:若中美關稅戰能顯著降溫 料中資科網、消費品和醫療板塊造好 但建議短期保持耐心及採平衡策略

2025-04-24T  
《大行》中金列出內地主動偏股型基金首季重倉港股情況(表)

2025-04-23T  
《大行》高盛列出美機構投資者對中概股在香港及美國市場持股佔比預測(表)

2025-04-17T  
關稅衝擊印度藥企 恐推升美國醫療成本

2025-04-16T  
《港股》恆指低開2,119點或9% 科指低開逾11% 醫藥股跌幅居前

2025-04-07T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.